molecular mind

Heart of Molecules is a platform company focusing on AI protein design, founded by Prof. Jinbo Xu, a computational biologist and the founder of global AI protein folding technology.

Company Overview

• Established: January 20, 2022
• creatorMr. Xu Jinbo (Professor, Toyota Institute of Computing Technology, Chicago, USA; Visiting Professor, BIOPIC, Peking University)
• registered capital: 7,947,000 RMB
• Scope of businessIncluding production of Class I medical devices, sales of medical devices (Class I and II), software development, etc.
• Company Vision: To establish a world-class computational biology discipline in China and to promote the industrial-scale transformation of scientific and technological achievements.

technical strength

• core technologyMoleculeOS has developed more than a dozen industry-leading AI protein prediction, optimization and design algorithms, including the world's first fully-functional AI protein prediction, optimization and design platform "MoleculeOS". The platform utilizes a data-driven deep learning approach to help biotechnologists quickly identify and generate the most suitable proteins, and rapidly scale laboratory research results to industrial-scale applications.
• InnovationsNewOrigin, the industry-level AI protein generation model independently developed by Heart of Molecules, is the world's only AI protein base model that integrates sequence, structure, function and evolution. With tens of billions of parameters, the model can be used to customize functional proteins according to the needs of industrial applications, and has made significant breakthroughs in a number of fields, such as large molecule drug design, protein stability optimization in extreme environments, and enzyme activity optimization.

Milestones

• Financing::

  • In April 2022, Molecular Heart completed an angel round of financing of tens of millions of dollars, led by Sequoia China and followed by Baidu Ventures, LifePark Venture Capital Fund, Core Aviation Capital, and Future Qichuang.
  • In February 2023, it received a strategic investment of over 100 million RMB, led by synthetic biology leader Kaiser Biologics, followed by Lenovo Venture Partners, with additional investment from Sequoia China, the leading investor in the angel round.
  • On September 13, 2024, it completed hundreds of millions of yuan of Series A financing, jointly led by Xeno Investment and Shenzhen Venture Capital, followed by Shangtang Guoxiang Capital and Jiuyi Investment. This round of financing will be used to further expand the composite talent team, deeply improve the AI protein basic big model, AI protein optimization design platform MoleculeOS and other technology platforms, and accelerate the industrial landing and commercialization of AI protein technology.

• Research and Industrial Applications: Heart of Molecules actively carries out linkage with foreign counterparts and plans to build professional R&D laboratories synchronously around the world. Based on Xu Jinbo's previous scientific research results, the company carries out scientific research and industrial application for AI protein prediction and design, and establishes cooperation with national life science and medical laboratories to promote the transformation of AI protein research and design results. At the same time, Heart of Molecules also applies the AI macromolecule optimization and design platform to synthetic biology and other fields, bringing changes to a wider range of fields such as energy, materials, agriculture, industry, food and consumer products.

Industry Impact and Future Outlook

• Industry Impact: Heart of Molecules' groundbreaking work in the field of AI protein design has not only pushed forward the progress of basic scientific research, but also accelerated the application of cutting-edge scientific research results in the industry, bringing disruptive changes in the fields of drug discovery and development, and biomanufacturing.
• future outlookProf. Xu Jinbo expressed his hope that Heart of Molecules will become the "Merck of the AI era" and bring greater benefits to human health and social development. In the future, Heart of Molecules will continue to work hard in the field of AI protein design, promote the generation and transformation of more innovative results, and make greater contributions to the development of global life sciences and healthcare.